Dana Sullivan
Psychiatric/Mental Health · Evesham, NJNPI 1245998053
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 25.6% of the total. 2025 is the largest year on record at $1,263, 2.2 times the $564 reported in 2022. Among psychiatric/mental health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 253 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$590
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$335
- Neurocrine Biosciences, Inc.$285
- Axsome Therapeutics, Inc.$283
- Lundbeck LLC$224
- plus $1K from 15 others
What the payments were for
- Food & beverage$3,88199%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 71 | $1,005 |
| Otsuka America Pharmaceutical, Inc. | 37 | $590 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 19 | $335 |
| Neurocrine Biosciences, Inc. | 16 | $285 |
| Axsome Therapeutics, Inc. | 19 | $283 |
| Lundbeck LLC | 14 | $224 |
| Vanda Pharmaceuticals Inc. | 14 | $221 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $160 |
| Corium, LLC | 12 | $150 |
| Alkermes, Inc. | 7 | $119 |
| Teva Pharmaceuticals USA, Inc. | 6 | $100 |
| Bausch Health US, LLC | 5 | $77 |
| Neos Therapeutics, LP | 5 | $75 |
| Collegium Pharmaceutical, Inc. | 4 | $72 |
| Tris Pharma Inc | 4 | $63 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Almatica Pharma LLC | 2 | $33 |
| Noven Therapeutics, LLC | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $29 |
| Neuronetics, Inc. | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$125
How this compares
$3,928 in reported general payments places this provider in the 90th percentile of 1,212 psychiatric/mental health providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| SpravatoEsketamine Hcl | 19 | $24,401 |
| Aripiprazole | 20 | $831 |
| Duloxetine Hcl | 25 | $558 |
| Bupropion XlBupropion Hcl | 20 | $442 |
| Gabapentin | 19 | $402 |
| Fluoxetine Hcl | 18 | $394 |
| Clonazepam | 28 | $370 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $276 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $260 |
| Lithium Carbonate ErLithium Carbonate | 12 | $196 |
| Trazodone Hcl | 20 | $176 |
| Escitalopram Oxalate | 15 | $122 |
| Lorazepam | 24 | $121 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Evesham
- Ubong UdofiaMarlton$407K
- Anthony DimuraRed Bank$130K
- Amy PinsenNewton$111K
- Aaron SpectorMarlton$100K
- Fiorella ParadisiSparta$84K
- Diane BurtBridgeton$81K
- Alta ManessHackensack$75K
- Laura LeahySewell$41K
- Linda WinfulMontclair$40K
- Marisa SavicOradel$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.